Investor Announcements - 2011

EKF wins IMSS contract

30^th Nov 2011

EKF Diagnostics has been awarded a contract in Mexico for 3,500 HemoPoint H2 haemoglobin testing devices.

Announcement of Interim Results

28^th Sep 2011

EKF Diagnostics Holdings plc announces its unaudited interim results for the six month period ended 30 June 2011, a period of transition, investment and progression.

Distribution agreement with Alere

23^rd May 2011

EKF Diagnostics announces that it has entered into a conditional distribution agreement with Alere Inc.

EKF announces acquisition of Stanbio Laboratory

23^rd May 2011

Proposed acquisition of the entire issued share capital of Stanbio Laboratory L.P.

Quotient Diagnostics receives SFDA approval

27^th Jan 2011

Quotient Diagnostics has received approval from China’s SFDA for its Quo-Test A1C test.

Archive

Mount Sinai investments related
RNS announcements

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF to showcase POCT and medical device connectivity solutions at Medlab Middle East 2023

EKF launches handheld veterinary lactate analyzer

EKF to showcase POCT connectivity solutions at MEDICA 2022

Powerful digital connectivity products and contract manufacturing capabilities in Hall 3 at Stand B69

EKF introduces hand-held hemoglobin analyzer with secure POC connectivity

DiaSpect Tm POC hemoglobin analyzer now powered by EKF Link digital connectivity solution

Medica 2022

Medica is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every professional's calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.